|
Company:
|
NEOGENOMICS INC (NEO)
|
|
Form Type:
|
4
|
|
Filing Date:
|
6/4/2020
|
|
CIK:
|
0001077183
|
|
Address:
|
12701 COMMONWEALTH DRIVE
SUITE 9
|
|
City, State, Zip:
|
FORT MYERS, Florida 33913
|
|
Telephone:
|
(941) 923-1949
|
|
Fiscal Year:
|
12/31
|
|
|
|
|
|
Last Trade
|
Last Trade:
$53.53
|
Change:
-1.39 (-2.53%)
|
Trade Time:
Jan 27
|
Market Cap:
$6.16B
|
|
|
|
|
|
|
Description of Business
|
|
NeoGenomics, Inc., a Nevada corporation (referred to individually as the "Parent
Company" or collectively with its subsidiaries as "NeoGenomics", "we", "us",
"our" or the "Company" in this Annual Report) is the registrant for SEC
reporting purposes. Our common stock is listed on the NASDAQ Capital Market
under the symbol "NEO".
Overview
We operate a network of cancer-focused testing laboratories in the United States
as well as laboratories in Switzerland and Singapore. Our mission is to improve
patient care through exceptional cancer-focused testing services. Our vision is
to be the World's leading cancer testing and information company by delivering
uncompromising quality and innovative solutions while providing exceptional
service and operating with a world-class culture.
|
|
|
|